Donepezil (Aricept) Treatment for Mild to Moderate Alzheimer's Disease
For mild to moderate Alzheimer's disease, donepezil should be initiated at 5 mg once daily in the evening, with an increase to 10 mg once daily after 4-6 weeks if well tolerated. 1, 2, 3
Dosing Recommendations
- Start with 5 mg donepezil once daily in the evening, just prior to retiring 1
- After 4-6 weeks, consider increasing to 10 mg once daily if the initial dose is well tolerated 1, 2
- Donepezil can be taken with or without food; taking with food may reduce gastrointestinal side effects 2, 3
- The maximum recommended dosage for mild to moderate Alzheimer's disease is 10 mg per day 1
Efficacy and Expected Benefits
- Donepezil produces clinically meaningful improvements in cognitive function and global clinical state in patients with mild to moderate Alzheimer's disease 2, 3
- Benefits include a statistically significant improvement in cognition (2-3 points on the ADAS-Cog scale) compared to placebo 4, 5
- Efficacy has been demonstrated for up to 4.9 years of treatment 2
- Benefits on cognitive function, activities of daily living, and behavior can be maintained for approximately 21 to 81 weeks with donepezil 10 mg/day 3
- The 10 mg dose provides marginally greater benefits than the 5 mg dose, but with higher rates of adverse events 4
Monitoring Response
- Beneficial response should be assessed after 6-12 months of treatment 2
- Response is determined by physician's global assessment, caregiver reports, neuropsychologic assessments, or evidence of behavioral/functional changes 2
- Brief mental status tests alone are relatively insensitive measures of donepezil's cognitive effects 2
- Expect modest benefits (equivalent to delaying cognitive decline by approximately one year) 2
Side Effects and Management
- Common adverse effects include nausea, vomiting, diarrhea, and anorexia, which are dose-dependent and more common at 10 mg versus 5 mg 3, 5
- Some patients may experience an initial increase in agitation, which typically subsides after the first few weeks of therapy 2, 3
- Taking donepezil with food can help reduce gastrointestinal side effects 2, 6
- Consider discontinuing if side effects persist and don't resolve, if adherence is poor, or if deterioration continues at the pre-treatment rate after 6-12 months 2
Important Considerations and Pitfalls
- Communicate the expected modest benefits to patients and caregivers before initiating treatment 2
- Avoid starting at high doses, as gradual titration improves tolerability 3
- Administer in the evening rather than morning to minimize sleep disturbances 1
- Avoid expecting dramatic clinical improvement, as effects are statistically significant but modest in magnitude 3
- If a patient doesn't respond to donepezil, they may respond to another cholinesterase inhibitor 2
- Donepezil is not recommended for mild cognitive impairment as evidence shows no significant benefit 3
Alternative Dosing Considerations
- For moderate to severe Alzheimer's disease, dosing can be increased to 23 mg once daily, but only after patients have been on 10 mg daily for at least 3 months 1
- The 23 mg tablet should not be split, crushed, or chewed 1
- Studies show that benefits on 23 mg/day were no greater than on 10 mg/day, but with higher rates of adverse events 4